Suppr超能文献

肝细胞癌的自发消退通常与肿瘤缺氧或全身炎症反应有关。

Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response.

机构信息

Department of Surgery, New York University School of Medicine, NY 10029, USA.

出版信息

HPB (Oxford). 2012 Aug;14(8):500-5. doi: 10.1111/j.1477-2574.2012.00478.x. Epub 2012 May 15.

Abstract

BACKGROUND

Spontaneous regression of hepatocellular carcinoma (HCC) is well documented, although the aetiology of this phenomenon remains unknown.

METHODS

A review of the English literature was performed for reports of spontaneous regression of HCC. Reports were classified by mechanism based on the available information.

RESULTS

Spontaneous regression of HCC has been identified in 75 patients. The most common mechanisms of regression identified were tumour hypoxia (n= 21, 28.0%), a systemic inflammatory response (n= 25, 33.3%) and unknown (n= 29, 38.7%). In patients where tumour hypoxia was described as the aetiology, mechanisms included spontaneous hepatic artery thrombosis and sustained systemic hypotension. In patients where a systemic inflammatory response was the aetiology, mechanisms included cholangitis, trauma and elevated cytokine levels.

DISCUSSION

Spontaneous regression of HCC is most commonly associated with tumour hypoxia or a systemic inflammatory response. Determining the aetiology of spontaneous regression may identify potential therapeutic pathways. Tumour hypoxia is already the basis of treatment modalities such as hepatic artery embolization and the anti-angiogenic agent sorafenib. However, treatment modalities for HCC do not currently include immune-directed therapies; this may prove to be a worthy target for future research.

摘要

背景

肝细胞癌(HCC)的自发消退已有明确记载,尽管其发病机制仍不清楚。

方法

对 HCC 自发消退的英文文献进行了回顾。根据现有资料,根据机制对报告进行了分类。

结果

在 75 例患者中发现 HCC 自发消退。确定的最常见消退机制是肿瘤缺氧(n=21,28.0%)、全身性炎症反应(n=25,33.3%)和未知原因(n=29,38.7%)。在描述肿瘤缺氧为病因的患者中,机制包括自发性肝动脉血栓形成和持续系统性低血压。在因全身性炎症反应为病因的患者中,机制包括胆管炎、创伤和细胞因子水平升高。

讨论

HCC 的自发消退最常与肿瘤缺氧或全身性炎症反应有关。确定自发消退的病因可能会发现潜在的治疗途径。肿瘤缺氧已经是肝动脉栓塞和抗血管生成药物索拉非尼等治疗方法的基础。然而,目前 HCC 的治疗方法不包括免疫导向治疗;这可能是未来研究的一个有价值的目标。

相似文献

2
Spontaneous regression of hepatocellular carcinoma: A mini-review.肝细胞癌的自发消退:一篇综述。
World J Gastroenterol. 2017 Jun 7;23(21):3797-3804. doi: 10.3748/wjg.v23.i21.3797.
4
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma.缺氧与肝细胞癌:肝细胞癌的治疗靶点
J Gastroenterol Hepatol. 2007 Aug;22(8):1178-82. doi: 10.1111/j.1440-1746.2007.04997.x. Epub 2007 Jun 7.
9
Spontaneous regression of hepatocellular carcinoma.
Histopathology. 1998 Feb;32(2):147-50. doi: 10.1046/j.1365-2559.1998.00340.x.

引用本文的文献

本文引用的文献

1
Sorafenib for treatment of hepatocellular carcinoma: a systematic review.索拉非尼治疗肝细胞癌:系统评价。
Dig Dis Sci. 2012 May;57(5):1122-9. doi: 10.1007/s10620-012-2136-1. Epub 2012 Mar 27.
4
Spontaneous complete regression of hepatocellular carcinoma.肝细胞癌自发完全消退。
Med Oncol. 2011 Dec;28(4):948-50. doi: 10.1007/s12032-010-9562-8. Epub 2010 May 14.
7
Spontaneous regression of hepatocellular carcinoma: a systematic review.肝细胞癌自发消退:系统综述。
Eur J Gastroenterol Hepatol. 2009 Mar;21(3):254-7. doi: 10.1097/MEG.0b013e328324b6a2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验